Skip to main content
Clinical Trials/CTRI/2022/06/043022
CTRI/2022/06/043022
Completed
Phase 3

An Interventional Study To Assess The Effectiveness Of Naphthalinum In The Management Of Allergic Rhinitis

Dr MPK Homoeopathic Medical College Hospital and Research Center0 sites45 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: J309- Allergic rhinitis, unspecified
Sponsor
Dr MPK Homoeopathic Medical College Hospital and Research Center
Enrollment
45
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
June 28, 2023
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Dr MPK Homoeopathic Medical College Hospital and Research Center

Eligibility Criteria

Inclusion Criteria

  • 1\. Diagnostic criteria: Presence of at least two typical symptoms mentioned below:
  • nasal obstruction
  • rhinorrhoea (also secretion running down the posterior pharynx)
  • occurring for more than an hour a day for more than 2 weeks in a year
  • 2\. Patients giving consent for the study.
  • 3\. Patients’ symptoms corresponding to Naphthalinum
  • 4\. Diagnosed cases of Allergic Rhinitis, taking treatment from other systems of medicine, feeling no relief and seeking homoeopathic treatment.

Exclusion Criteria

  • 1\. Females, who want to conceive, are pregnant or lactating.
  • 2\. Patients with any other severe systemic disorder.
  • 3\. Patients pursuing other treatments are not willing to leave it.
  • 4\. Allergic Rhinitis complicated with any other serious disease.
  • 5\. Cases that need surgical intervention.
  • 6\. The cases require emergency treatment.

Outcomes

Primary Outcomes

Not specified

Similar Trials